Infosys has approved the acquisition of 2 US-based companies, Optimum Healthcare IT and Stratus Global LLC, with a combined value of up to $560 million.
As per the filing, the decision was cleared by the board on 25 March 2026. Both transactions are expected to be completed in the first quarter of FY2027, subject to regulatory approvals and closing conditions.
The acquisitions will be carried out through Infosys Nova Holdings LLC, a wholly owned subsidiary. The deals are structured as cash transactions and do not fall under related party transactions.
The acquisition of Optimum Healthcare IT is valued at up to $465 million, including upfront payments and earn-outs. The purchase excludes management incentives and retention-related payouts.
In comparison, Stratus Global LLC will be acquired for up to $95 million under a similar structure. Infosys will acquire 100% ownership in both entities upon completion of the transactions.
No regulatory approvals are required for the Stratus deal, while the Optimum acquisition will need clearances under US competition laws.
Optimum Healthcare IT operates in healthcare technology consulting and is headquartered in Florida. Founded in 2012, the company employs over 1,600 professionals and focuses on digital transformation, enterprise applications, and workforce solutions for healthcare providers.
The company reported revenue of $275.9 million in FY2025. This compares with $106.6 million in FY2024 and $114.3 million in FY2023, indicating fluctuations over the 3-year period.
Its services include implementation and support of health record systems, along with consulting for hospitals and health systems.
Stratus Global LLC operates in the insurance technology segment, with a focus on property and casualty insurers. Founded in 2001 and based in New Jersey, the company has a workforce of over 450 professionals.
It provides services related to Guidewire platforms, including policy, billing, and claims systems, as well as cloud migration and data management.
Stratus reported revenue of $42.8 million in FY2025, compared with $36.2 million in FY2024 and $35.1 million in FY2023.
Read More: HUDCO ₹1.25 Interim Dividend Record Date is Tomorrow, March 28!
As of March 27, 2026, 9:48 am, Infosys Ltd share price was trading at ₹1,285.50, up 0.50% from the previous closing price.
The 2 acquisitions add capacity in healthcare and insurance technology services. The transactions also expand Infosys’ presence in the US market through additional clients, workforce, and domain-specific operations.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 27, 2026, 10:24 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
